Oxiconazole Nitrate Cream
NDC Package 0168-0358-30
Package Information
Oxiconazole Nitrate cream is oxiconazole is used to treat skin infections such as athlete's foot, jock itch and ringworm. This formulation utilizes a cream delivery system. Marketed by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc, this product is identified by NDC 0168-0358 and is authorized under FDA application NDA019828.
Identification & Billing
- RxCUI: 312139 - oxiconazole nitrate 1 % Topical Cream
- RxCUI: 312139 - oxiconazole 10 MG/ML Topical Cream
- RxCUI: 312139 - oxiconazole (as oxiconazole nitrate) 1 % Topical Cream
- RxCUI: 312139 - oxiconazole 1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0168 - E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc
- 0168-0358 - Oxiconazole Nitrate
- 0168-0358-30 - 30 g in 1 TUBE
- 0168-0358 - Oxiconazole Nitrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0168-0358). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0168-0358-30 identifies a specific commercial package of 30 g in 1 tube of Oxiconazole Nitrate, a human prescription drug labeled by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc. This cream is formulated for topical use and contains oxiconazole nitrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc on March 09, 2016. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Oxiconazole is used to treat skin infections such as athlete's foot, jock itch and ringworm. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Oxiconazole is an azole antifungal that works by preventing the growth of fungus.
How is this E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00168035830. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.